News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Jarushka Naidoo: Signing off on another great ELCC25
Jarushka Naidoo/X
Apr 1, 2025, 11:42

Jarushka Naidoo: Signing off on another great ELCC25

Jarushka Naidoo, Full Professor and Consultant Medical Oncologist at Royal College of Surgeons in Irelan, posted on X:

“Signing off on another great ELCC25!

Thanks ESMO for the opportunity to spend quality time with the best of people, present, chair, and record the next episode of Diary of an Oncology Leader for Women 4 Oncology.”

Jarushka Naidoo: Signing off on another great ELCC25

cancer Diary of an Oncology Leader ELCC25 ESMO Jarushka Naidoo OncoDaily Oncology Women 4 Oncology
Special Coverage
Blog
May 16, 2025, 13:31
Anju Aledia: Exploring Science up Close with a Magnifying Glass
Blog
May 16, 2025, 13:24
Amil Družić: The European School of Oncology's Improving Cancer Outcomes and Leadership Course in Zagreb
Oncolibrary
May 16, 2025, 13:21
FDA Approves Retifanlimab-dlwr with Chemotherapy and as Monotherapy for Advanced Squamous Cell Carcinoma of the Anal Canal
Blog
May 16, 2025, 13:01
How Countries are Engaging Stakeholders in the Development and Implementation of NCCPs - Union for International Cancer Control
Oncolibrary
May 16, 2025, 12:59
Eating Well with Mesothelioma: What You Need to Know
Blog
May 16, 2025, 12:54
Douglas Flora: Fantastic day Connecting with the Incredible Leaders at St. Elizabeth Healthcare
Blog
May 16, 2025, 12:37
Impact of Research Through Maggie’s Lung Cancer Journey - LUNGevity Foundation
Blog
May 16, 2025, 12:28
Giulio Draetta: A $150 million Gift from Kinder Foundation
Blog
May 16, 2025, 12:19
Environmental Risk Factors of Wilms Tumour - Childhood Cancer and Leukemia International Consortium
Science
May 16, 2025, 12:17
ROSALINE Trial Reports 49% Response in Lobular Breast Cancer at ESMO 2025
Oncolibrary
May 16, 2025, 11:45
DESTINY-Breast06 Trial Updates at ESMO Breast 2025 Confirms T-DXd Efficacy in HER2-Low and Ultralow Metastatic Breast Cancer
Blog
May 16, 2025, 11:26
Antonio Giordano: Important question - which 1L CDK4/6i to preserve efficacy of re-cycling cell cycle in 2L?